Petition Requests Pre-Market Approval For Supplement Weight-Loss Claims
This article was originally published in The Tan Sheet
Executive Summary
Manufacturers would need pre-market approval to make weight-loss claims for supplements if FDA implements a rulemaking recommended by petitioners, including GlaxoSmithKline, the manufacturer of OTC weight-loss drug alli.
You may also be interested in...
Glaxo’s Weight-Loss Petition Relied On “Deeply Flawed” Survey – AHPA
The American Herbal Products Association says GlaxoSmithKline used data from a flawed consumer survey when the firm asked FDA to reclassify weight loss claims as disease claims
Glaxo’s Weight-Loss Petition Relied On “Deeply Flawed” Survey – AHPA
The American Herbal Products Association says GlaxoSmithKline used data from a flawed consumer survey when the firm asked FDA to reclassify weight loss claims as disease claims
Glaxo’s Weight-Loss Petition Relied On “Deeply Flawed” Survey – AHPA
The American Herbal Products Association says GlaxoSmithKline used data from a flawed consumer survey when the firm asked FDA to reclassify weight loss claims as disease claims